C-ISLE: Grazoprevir/Elbasvir plus Sofosbuvir in Treatment-naive and Treatment-experienced HCV GT3 Cirrhotic Patients Treated for 8, 12 or 16 weeks

GR Foster; K Agarwal; M Cramp; S Moreea; ST Barclay; J Collier; AS Brown; SD Ryder; A Ustianowski; DM Forton; R Fox; F Gordon; WM Rosenberg; DJ Mutimer; J Du; CL Gilbert; J Wahl; E Barr; B Haber

C-ISLE: Grazoprevir/Elbasvir plus Sofosbuvir in Treatment-naive and Treatment-experienced HCV GT3 Cirrhotic Patients Treated for 8, 12 or 16 weeks

GR Foster, K Agarwal, M Cramp, S Moreea, ST Barclay, J Collier, AS Brown, SD Ryder, A Ustianowski, DM Forton, R Fox, F Gordon, WM Rosenberg, DJ Mutimer, J Du, CL Gilbert, J Wahl, E Barr, B Haber

Peninsula Medical School

Research output: Contribution to journal › Conference proceedings published in a journal › peer-review

Original language	English
Pages (from-to)	39A-40A
Number of pages	0
Journal	Hepatology
Volume	64
Issue number	0
Publication status	Published - 2016

Cite this

Foster, GR., Agarwal, K., Cramp, M., Moreea, S., Barclay, ST., Collier, J., Brown, AS., Ryder, SD., Ustianowski, A., Forton, DM., Fox, R., Gordon, F., Rosenberg, WM., Mutimer, DJ., Du, J., Gilbert, CL., Wahl, J., Barr, E., & Haber, B. (2016). C-ISLE: Grazoprevir/Elbasvir plus Sofosbuvir in Treatment-naive and Treatment-experienced HCV GT3 Cirrhotic Patients Treated for 8, 12 or 16 weeks. Hepatology, 64(0), 39A-40A.

@article{cd4e57d68c0c452882d6f346a582182d,

title = "C-ISLE: Grazoprevir/Elbasvir plus Sofosbuvir in Treatment-naive and Treatment-experienced HCV GT3 Cirrhotic Patients Treated for 8, 12 or 16 weeks",

author = "GR Foster and K Agarwal and M Cramp and S Moreea and ST Barclay and J Collier and AS Brown and SD Ryder and A Ustianowski and DM Forton and R Fox and F Gordon and WM Rosenberg and DJ Mutimer and J Du and CL Gilbert and J Wahl and E Barr and B Haber",

year = "2016",

language = "English",

volume = "64",

pages = "39A--40A",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Lippincott Williams and Wilkins",

number = "0",

}

Foster, GR, Agarwal, K, Cramp, M, Moreea, S, Barclay, ST, Collier, J, Brown, AS, Ryder, SD, Ustianowski, A, Forton, DM, Fox, R, Gordon, F, Rosenberg, WM, Mutimer, DJ, Du, J, Gilbert, CL, Wahl, J, Barr, E & Haber, B 2016, 'C-ISLE: Grazoprevir/Elbasvir plus Sofosbuvir in Treatment-naive and Treatment-experienced HCV GT3 Cirrhotic Patients Treated for 8, 12 or 16 weeks', Hepatology, vol. 64, no. 0, pp. 39A-40A.

TY - JOUR

T1 - C-ISLE: Grazoprevir/Elbasvir plus Sofosbuvir in Treatment-naive and Treatment-experienced HCV GT3 Cirrhotic Patients Treated for 8, 12 or 16 weeks

AU - Foster, GR

AU - Agarwal, K

AU - Cramp, M

AU - Moreea, S

AU - Barclay, ST

AU - Collier, J

AU - Brown, AS

AU - Ryder, SD

AU - Ustianowski, A

AU - Forton, DM

AU - Fox, R

AU - Gordon, F

AU - Rosenberg, WM

AU - Mutimer, DJ

AU - Du, J

AU - Gilbert, CL

AU - Wahl, J

AU - Barr, E

AU - Haber, B

PY - 2016

Y1 - 2016

M3 - Conference proceedings published in a journal

SN - 0270-9139

VL - 64

SP - 39A-40A

JO - Hepatology

JF - Hepatology

IS - 0

ER -